ARTICLE | Company News
Alexion research extension
February 10, 2000 8:00 AM UTC
ALXN will extend its collaboration with Austin Research Institute to develop and commercialize Austin's alpha1,3 galactosyltransferase and the jointly owned fucosyltransferase for use in cell and tiss...